Do lymphocytes contain chromosomal lesions that are also stable markers in cancer cells? Lymphocyte and tumor cell karyotyping in a melanoma patient

International Journal of Oncology

Volumn 11, Issue 4, 1997, Pages 681-684

  Ghayee, Hans K ^a,b   Dinney, Colin P ^a   Pathak, Sen ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Chromosome abnormalities; Diagnosis; Marker chromosomes; Melanoma cells; Metastasis; Peripheral blood lymphocyte

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CHROMOSOME DAMAGE; CYSTECTOMY; CYTOGENETICS; EARLY DIAGNOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPING; MALE; MELANOMA; METASTASIS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0030961193     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Pathak S: Cytogenetics of epithelial malignancies. Cancer 70: 1660-1670, 1992.
2. Kamb A, Gruis NA, Weaver-Feldhous J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS III, Johnson BE and Skolnick M: A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440, 1994.
3. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K and Carson D: Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancer. Nature 368: 753-756, 1994.
4. Marlo A, Gabrielson E, Askin F and Sidransky D: Frequent loss of chromosome 9 in human primary non-small cell lung cancer. Cancer Res 54: 640-642, 1994.
5. Pathak S, Dhaliwal MK and Hopwood VL: Genetic susceptibility, somatic mosaicisms and predisposition to human cancer. Anticancer Res 9: 17-20, 1989.
6. Pathak S, Hopwood VL, Hughes JI and Jackson GL: Identification of colon cancer-predisposed individuals: a cytogenetic analysis. Am J Gastroenterol 86: 679-684, 1991.
7. Pathak S, Hopwood VL, Hortobagyi GN, Jackson GL, Hughes JI and Melillo D: Chromosome anomalies in human breast cancer: evidence for specific involvement of 1q region in lymphocyte cultures. Anticancer Res 11: 1055-1060, 1991.
8. Pathak S: Cytogenetics of solid tumors: renal cell carcinoma, malignant melanoma, retinoblastoma and Wilms' tumor. In: The Human Oncogenic Viruses: Molecular Analysis and Diagnosis. Luderer AA and Weetall HH (eds). The Humana Press, Inc., Clifton, NJ, pp43-87, 1986.
9. Pathak S: Cytogenetic abnormalities in cancer: with special emphasis on tumor heterogeneity. Cancer Metastasis Rev 8: 299-318, 1990.
10. Dave BJ, Hopwood VL, Hughes JI, Jackson GL, Melillo D and Pathak S: Cytogenetic abnormalities in colon cancer patients: a comparison of T- and B-lymphocytes. Anticancer Res 13: 433-438, 1993.
11. Dave BJ, Hsu TC, Hong WK and Pathak S: Nonrandom distribution of mutagen-induced chromosome breaks in lymphocytes of patients with different malignancies. Int J Oncol 5: 733-740, 1994.
12. Dave BJ, Hopwood VL, King TM Ziang H, Spitz MR and Pathak S: Genetic susceptibility to lung cancer as determined by lymphocytic chromosome analysis. Cancer Epidemiol Biomarkers Prev 4: 743-749, 1995.
13. Mitelman F: Catalog of Chromosome Aberrations in Cancer. 4th edition. John Wiley & Sons, Inc., New York, 1993.
14. Pathak S, Berry KK, Hopwood VL, Burke TW and Baker VV: Identification of primary chromosome abnormalities in a patient with endometrial carcinoma: analyses of tumor biopsy and lymphocyte cultures. Int J Oncol 7: 765-772, 1995.
15. Pathak S: Chromosome banding techniques. J Reprod Med 17: 25-28, 1976.
16. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Pue J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH and Parsons R: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947, 1997.
17. Pathak S, Drwinga HL and Hsu TC: Involvement of chromosome no. 6 in rearrangements in human malignant melanomas. Cytogenet Cell Genet 36: 573-579, 1983.
18. Trent JM, Thompson FH and Meyskens FL: Identification of a recurring translocation site involving chromosome 6 in human malignant melanoma. Cancer Res 49: 420-423, 1989.
19. Trent JM, Stanbridge FJ, McBride HL, Meese EU, Casey G, Araujo DE, Witkowski CM and Nagle RB: Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. Science 247: 568-571, 1990.